CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Financial Officer sold 3,524 shares at $72.69 ($256,160)
- 4 Planned sale Chief Executive Officer sold 20,000 shares at an average $72.48 ($1,449,628)
- 144 Insider Sale of Securities
- 4 Open-market sale General Counsel and Secretary sold 3,947 shares at an average $77.15 ($304,515)
- 4 Open-market sale Chief Executive Officer sold 14,385 shares at an average $77.04 ($1,108,263)
- 4 Grant or award Director acquired 1,048,951 shares (grant or award)
- 4 Open-market sale General Counsel and Secretary sold 1,913 shares at $79.67 ($152,409)
- 4 Open-market sale Chief Executive Officer sold 6,370 shares at $79.67 ($507,498)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Planned sale Chief Executive Officer sold 20,000 shares at an average $80.36 ($1,607,177)
- 144 Insider Sale of Securities
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Other events
Page 11 of 45 · 883 filings